Chris Allen, Executive Director of Hemp Federation Ireland, elaborates on the Irish authorities’ legal turmoil over hemp and CBD.
HEMP Federation Ireland has advised the EU Commission’s Health Executive of a dangerously confused situation in the Irish justice system following a scientifically unsupported CBD ruling of the Irish High Court in November.
In an extraordinary reading of the KanaVape decision the Irish Court concludes that the EU ruling of November 2020 related only to the CBD portion of the KanaVape product and not to the product itself.
The court judgement, which was published on November 11, confirms that synthetic and isolated CBD products can be considered as EU food but natural hemp extracts, where they contain any trace of THC, are dangerous narcotics in ‘Irish, European and international law’ and must only be available under medical supervision.
The ruling advises that the provisions of Article 34 of the Treaty Forming the European Union (TFEU) do not apply.
Threat To Health!
The Irish Court then relies on World Health Organisation research into the human health impacts of consuming trafficked drugs to determine that products regulated as food by the European Food Safety Authority pose scientifically established risks to human health.
However, the European Commission does not regulate consumer goods where they are narcotics and EU food law does not permit medicines to be presented as food.
Products regulated as food by the European Food Safety Authority are automatically entitled to the free trade protections of Article 34 of TFEU.
Article 34 of TFEU requires Member States to first provide relevant science demonstrating an actual threat to human health before such an approach is adopted.
The World Health Organisation has repeatedly clarified that food containing trace impurities of THC below 0.2% pose no risk to human health, according to available science.
When Irish Health authorities refused to clarify relevant matters of fact, of EU law and of science, Hemp Federation Ireland requested an urgent and immediate intervention from the European Commission to protect Irish citizens, European food consumers and the Irish and European Hemp industry.
‘Well-Received’ Submission
In response to a follow up email on January 8, the European Commission advises that HFI’s request is ‘well received’.
The Irish ruling sits in stark contrast to the December 29 decision of the French Council of State which protected the rights of French citizens by correctly applying Articles 34 & 36 of TFEU in compliance with the KanaVape ruling.
The EU Commission is already investigating Ireland’s multiple failures to uphold EU law and the Court of Justice ruling, including a post-KanaVape decision by Ireland’s Minister for Health to define the EU hemp crop as a controlled drug for the purposes of section 13 (1) (a) of the Irish Misuse of Drugs Act 1977.
This intervention allows Ireland’s Minister for Health to subject the crop, all derived products and the entire agricultural hemp supply chain to the strict licensing regime of Section 14 of the Irish Drugs Act.
Although the Minister justified his approach based on a need to protect human life and health, no scientific justification whatsoever was provided.
In May last year, an interlocutory judgement of the Irish High Court had suspended the operation of relevant aspects of Ireland’s 1977 Act in order to protect Ireland’s hemp industry operators from a threat of ‘real and irreparable harm’.
The judge on that occasion upheld the KanaVape decision in its entirety and advised the State defendants that they must first produce scientific data as required by Article 34 TFEU before the hemp crop and products could lawfully be controlled as drugs for the purposes of the 1977 Misuse of Drugs Act.
The November High Court ruling now advises that the Minister for Health was right to take it upon himself to protect Irish hemp farmers from dangerous parts of their crop.
Only the Irish parliament can introduce legislation which creates a criminal offence which didn’t previously exist in the Irish statutes and the intervention appears in serious conflict with the Irish Constitution.
Nevertheless, Irish authorities will today resume the criminal prosecution of Irish hemp industry operators and members of the Irish public who buy consumer goods which are increasingly popular with EU food consumers and are widely available in shops throughout Ireland and Europe.
The extensive confusion that now exists is likely to impact the decisions of the lower Irish Courts in these criminal trials.
Clarifications Urgently Required
Hemp Federation Ireland is hopeful that European authorities will adopt a swift and decisive approach to assist Irish authorities in the correct interpretation and application of EU law in Ireland.
Hemp Federation Ireland members have pending judicial review cases due for immediate hearing in the Irish High Court. These much delayed cases will argue the full scope of EU and Irish constitutional law.
Irish authorities should wait for the outcomes of these cases before pursuing EU food consumers in the Irish courts.
However, as matters currently stand, the November ruling should be of serious concern to the European Commission and to all EU industry operators.
Hemp Federation Ireland is Ireland’s national hemp industry stakeholder body. We represent the common interests of Irish industry operators working with hemp fibre, shive, seeds, leaves, roots, flowers and cannabinoids.
Our membership spans the Irish industry value chain and includes Ireland’s longest established farms and businesses as well as the largest employers in the sector.
Ireland’s ‘Dangerously Confused’ Justice System Is Harming Europe’s Hemp And CBD Industry
Chris Allen, Executive Director of Hemp Federation Ireland, elaborates on the Irish authorities’ legal turmoil over hemp and CBD.
HEMP Federation Ireland has advised the EU Commission’s Health Executive of a dangerously confused situation in the Irish justice system following a scientifically unsupported CBD ruling of the Irish High Court in November.
In an extraordinary reading of the KanaVape decision the Irish Court concludes that the EU ruling of November 2020 related only to the CBD portion of the KanaVape product and not to the product itself.
The court judgement, which was published on November 11, confirms that synthetic and isolated CBD products can be considered as EU food but natural hemp extracts, where they contain any trace of THC, are dangerous narcotics in ‘Irish, European and international law’ and must only be available under medical supervision.
The ruling advises that the provisions of Article 34 of the Treaty Forming the European Union (TFEU) do not apply.
Threat To Health!
The Irish Court then relies on World Health Organisation research into the human health impacts of consuming trafficked drugs to determine that products regulated as food by the European Food Safety Authority pose scientifically established risks to human health.
However, the European Commission does not regulate consumer goods where they are narcotics and EU food law does not permit medicines to be presented as food.
Products regulated as food by the European Food Safety Authority are automatically entitled to the free trade protections of Article 34 of TFEU.
Article 34 of TFEU requires Member States to first provide relevant science demonstrating an actual threat to human health before such an approach is adopted.
The World Health Organisation has repeatedly clarified that food containing trace impurities of THC below 0.2% pose no risk to human health, according to available science.
When Irish Health authorities refused to clarify relevant matters of fact, of EU law and of science, Hemp Federation Ireland requested an urgent and immediate intervention from the European Commission to protect Irish citizens, European food consumers and the Irish and European Hemp industry.
‘Well-Received’ Submission
In response to a follow up email on January 8, the European Commission advises that HFI’s request is ‘well received’.
The Irish ruling sits in stark contrast to the December 29 decision of the French Council of State which protected the rights of French citizens by correctly applying Articles 34 & 36 of TFEU in compliance with the KanaVape ruling.
The EU Commission is already investigating Ireland’s multiple failures to uphold EU law and the Court of Justice ruling, including a post-KanaVape decision by Ireland’s Minister for Health to define the EU hemp crop as a controlled drug for the purposes of section 13 (1) (a) of the Irish Misuse of Drugs Act 1977.
This intervention allows Ireland’s Minister for Health to subject the crop, all derived products and the entire agricultural hemp supply chain to the strict licensing regime of Section 14 of the Irish Drugs Act.
Although the Minister justified his approach based on a need to protect human life and health, no scientific justification whatsoever was provided.
In May last year, an interlocutory judgement of the Irish High Court had suspended the operation of relevant aspects of Ireland’s 1977 Act in order to protect Ireland’s hemp industry operators from a threat of ‘real and irreparable harm’.
The judge on that occasion upheld the KanaVape decision in its entirety and advised the State defendants that they must first produce scientific data as required by Article 34 TFEU before the hemp crop and products could lawfully be controlled as drugs for the purposes of the 1977 Misuse of Drugs Act.
The November High Court ruling now advises that the Minister for Health was right to take it upon himself to protect Irish hemp farmers from dangerous parts of their crop.
Only the Irish parliament can introduce legislation which creates a criminal offence which didn’t previously exist in the Irish statutes and the intervention appears in serious conflict with the Irish Constitution.
Nevertheless, Irish authorities will today resume the criminal prosecution of Irish hemp industry operators and members of the Irish public who buy consumer goods which are increasingly popular with EU food consumers and are widely available in shops throughout Ireland and Europe.
The extensive confusion that now exists is likely to impact the decisions of the lower Irish Courts in these criminal trials.
Clarifications Urgently Required
Hemp Federation Ireland is hopeful that European authorities will adopt a swift and decisive approach to assist Irish authorities in the correct interpretation and application of EU law in Ireland.
Hemp Federation Ireland members have pending judicial review cases due for immediate hearing in the Irish High Court. These much delayed cases will argue the full scope of EU and Irish constitutional law.
Irish authorities should wait for the outcomes of these cases before pursuing EU food consumers in the Irish courts.
However, as matters currently stand, the November ruling should be of serious concern to the European Commission and to all EU industry operators.
Hemp Federation Ireland is Ireland’s national hemp industry stakeholder body. We represent the common interests of Irish industry operators working with hemp fibre, shive, seeds, leaves, roots, flowers and cannabinoids.
Our membership spans the Irish industry value chain and includes Ireland’s longest established farms and businesses as well as the largest employers in the sector.
The four states who could legalize adult-use cannabis in 2023
Next PostLinnea to expand high THC exports with Swiss licence
BusinessCann
Related Posts
Related Posts
Canada’s Cannabis Industry at a Turning Point After Trudeau’s Departure
As Canada’s cannabis industry stands at a pivotal crossroads, the impending departure of Prime Minister Justin Trudeau marks the end of an...
Celadon’s Shares Spike as Partnership Starts Generating Revenue, Phillip Morris Expands Cannabis Footprint, & More from DanCann Pharma
Celadon Pharmaceuticals Celadon Pharmaceuticals has seen its stock price spike this week after revealing that its supply agreement with...
Poland Eyes CBD Ban as its Medical Cannabis Crackdown Sees Prescription Numbers Plummet
Czech Republic Pushes Ahead With Pioneering ‘Psychomodulating Substances’ Regulation
Prime Minister Kretschmer of Saxony Visits Cannabis Group Grünhorn: “The Market for Medical Cannabis Has Great Potential”
Hundreds of UK Families Forced to Turn to Illicit Cannabis Market Due to Lack of NHS Access
CONNECT
Related Posts
Related Posts
Canada’s Cannabis Industry at a Turning Point After Trudeau’s Departure
As Canada’s cannabis industry stands at a pivotal crossroads, the impending departure of Prime Minister Justin Trudeau marks the end of an...
Celadon’s Shares Spike as Partnership Starts Generating Revenue, Phillip Morris Expands Cannabis Footprint, & More from DanCann Pharma
Celadon Pharmaceuticals Celadon Pharmaceuticals has seen its stock price spike this week after revealing that its supply agreement with...
Poland Eyes CBD Ban as its Medical Cannabis Crackdown Sees Prescription Numbers Plummet
Poland has seen the number of medical cannabis prescriptions plummet since it moved to crack down on telemedicine prescriptions. Telemedicine...
Czech Republic Pushes Ahead With Pioneering ‘Psychomodulating Substances’ Regulation
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed...
Prime Minister Kretschmer of Saxony Visits Cannabis Group Grünhorn: “The Market for Medical Cannabis Has Great Potential”
Today’s visit by Prime Minister Michael Kretschmer, part of the CDU, a party known for its critical stance on cannabis,...
Recent Posts
Related Posts
Poland Eyes CBD Ban as its Medical Cannabis Crackdown Sees Prescription Numbers Plummet
Poland has seen the number of medical cannabis prescriptions plummet since it moved to crack down on telemedicine prescriptions. Telemedicine...
UK CBD Business Sues Government for £3.4m Over ‘Unlawful’ Seizure of Hemp
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling...
DoorDash Begins Delivering CBD and Intoxicating Hemp Products
US store-to-door delivery giant DoorDash announced last week that it will begin offering CBD and intoxicating hemp substances through its...
UK Regulators Signal Goal for ‘Zero Detectable THC’ in CBD Products in Worrying Signs for Full Spectrum Advocates
This week, the UK Food Standards Agency (FSA) held its monthly board meeting to discuss, among other things, the future...
Japan’s CBD Industry Recieves First Investments From Publicly Listed Companies Following Recent Reforms
AstraSana Japan Co., Ltd. has formed a capital and business alliance with Japan’s GSI Creos Corporation, bolstered by their investment....
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags